RxPG News Feed for RxPG News

Medical Research Health Special Topics World
  Home
 
   Health
 Aging
 Asian Health
 Events
 Fitness
 Food & Nutrition
 Happiness
 Men's Health
 Mental Health
 Occupational Health
 Parenting
 Public Health
 Sleep Hygiene
 Women's Health
 
   Healthcare
 Africa
 Australia
 Canada Healthcare
 China Healthcare
 India Healthcare
 New Zealand
 South Africa
 UK
 USA
 World Healthcare
 
 Latest Research
 Aging
 Alternative Medicine
 Anaethesia
 Biochemistry
 Biotechnology
 Cancer
 Cardiology
 Clinical Trials
 Cytology
 Dental
 Dermatology
 Embryology
 Endocrinology
 ENT
 Environment
 Epidemiology
 Gastroenterology
 Genetics
 Gynaecology
 Haematology
 Immunology
 Infectious Diseases
 Medicine
 Metabolism
 Microbiology
 Musculoskeletal
 Nephrology
 Neurosciences
 Obstetrics
 Ophthalmology
 Orthopedics
 Paediatrics
 Pathology
 Pharmacology
 Physiology
 Physiotherapy
 Psychiatry
 Radiology
 Rheumatology
 Sports Medicine
 Surgery
 Toxicology
 Urology
 
   Medical News
 Awards & Prizes
 Epidemics
 Launch
 Opinion
 Professionals
 
   Special Topics
 Ethics
 Euthanasia
 Evolution
 Feature
 Odd Medical News
 Climate

Last Updated: Nov 2, 2013 - 11:50:46 AM
Research Article
Latest Research Channel

subscribe to Latest Research newsletter
Latest Research

   EMAIL   |   PRINT
Virtual monitoring could aid adherence to TB medication

Sep 8, 2013 - 4:00:00 AM
This has the potential to not only reach people who are otherwise unengaged, but also reduce costs and resources. A larger trial comparing the two techniques is needed to ensure the safety and reliability of this technique, and also determine who benefits most from this approach.

 
[RxPG] Barcelona, Spain: Virtual observation of patients taking their prescribed TB medication, could prove an effective technique for ensuring patients effectively complete their course of treatment.

The research will be presented today (8 September 2013) at the European Respiratory Society (ERS) Annual Congress.

The new study suggests an alternative method to directly observed treatment (DOT), which is recommended by the World Health Organization. Directly observing treatments is often time consuming for a patient and is resource intensive for outreach projects, which seek to help people who may not wish to visit a clinic.

The virtually observed treatment (VOT) method instead requires people to send a short video of them taking their medication, to their healthcare provider using a mobile phone. After an initial visit to the clinic, this can be completed remotely, with any issues being followed up when required.

Researchers from the Royal Free London NHS Foundation Trust piloted the effectiveness of the VOT technique. Nine people needing DOT commenced the programme. Two people returned no clips during the first week and were returned to the clinic-based approach. Of the remaining seven, six people returned video clips for a minimum of 95% of all treatment encounters.

Overall, the researchers observed 86% of scheduled doses. They concluded that this was a feasible method of monitoring TB treatment programmes in people able to use VOT.

Lead author, Sara Hemming, said: These preliminary findings suggest that telemedicine can help us overcome the difficulties we've seen in directly monitoring patients taking their medicine. Some people are unable or unwilling to visit clinics for a variety of reasons, but by enabling healthcare professionals to virtually monitor patients, we can still ensure effective medication use without the need for a one-to-one session.

This has the potential to not only reach people who are otherwise unengaged, but also reduce costs and resources. A larger trial comparing the two techniques is needed to ensure the safety and reliability of this technique, and also determine who benefits most from this approach.

European Respiratory Society President, Professor Francesco Blasi, said: The European Lung White Book, which is launched this week, calls on countries with high rates of TB, to set up strategies to manage the large numbers of people with drug-susceptible and multidrug-resistant-TB (MDR-TB). This study shows one way that could improve the effectiveness of treatments for people who are particularly hard-to-reach. The outcomes of this pilot study are positive and I look forward to seeing the results of a larger trial.



Related Latest Research News
How do consumers see a product when they hear music?
Drug activates virus against cancer
Bone loss associated with increased production of ROS
Sound preconditioning prevents ototoxic drug-induced hearing loss in mice
Crystal methamphetamine use by street youth increases risk of injecting drugs
Johns Hopkins-led study shows increased life expectancy among family caregivers
Moderate to severe psoriasis linked to chronic kidney disease, say experts
Licensing deal marks coming of age for University of Washington, University of Alabama-Birmingham
Simple blood or urine test to identify blinding disease
Physician job satisfaction driven by quality of patient care

Subscribe to Latest Research Newsletter

Enter your email address:


 Feedback
For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 
Contact us

RxPG Online

Nerve

 

    Full Text RSS

© All rights reserved by RxPG Medical Solutions Private Limited (India)